NHS Introduces Injectable Cancer Treatment to Reduce Hospital Time
The NHS has introduced a new injectable form of the cancer drug Keytruda, which could significantly reduce the time patients spend in hospitals. Previously administered through intravenous infusion, the new method allows the drug to be given as a quick injection, potentially saving hours for both patients and healthcare staff. Keytruda, a type of immunotherapy, helps the body's immune system attack cancer cells and is used to treat multiple types of cancer. This development follows the introduction of similar injectable treatments, such as Opdivo, in some hospitals last year. 
